Tvardi Therapeutics Inc. (TVRD) Live Share Price, Invest From India

Tvardi Therapeutics Inc. Stock Performance

as on June 19, 2026 at 2:16 pm IST

Day's Low
Day's High
$2.48
Day's Price Range
$2.65
$2.63
5.70%
Downside
0.76%
Upside
52 Week's Low
52 Week's High
$2.48
52-Week Price Range
$43.65
$2.63
5.89%
Downside
1559.70%
Upside

Tvardi Therapeutics Inc. share price movements today

Previous Close: $2.58
Open: $2.61
Volume: 251.0K
Day's Low - High: $2.48 - $2.65
52 Week Low - High: $2.48 - $43.65

Tvardi Therapeutics Inc. Historical Returns

1 Month Return: -29.11 %
3 Month Return: -28.53 %
1 Year Return: -89.72 %
3 Year Return: 0 %
5 Year Return: 0 %

Tvardi Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Tvardi Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$24.4M

EPS (TTM)

-2.39

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-237.81%

Tvardi Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tvardi Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Tvardi Therapeutics Inc.	NA	$24.4M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for Tvardi Therapeutics Inc. Stock including INR - Dollar returns

The Tvardi Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Tvardi Therapeutics Inc. investment value today

Current value as on today

₹11,195

Returns

-₹88,805

(-88.8%)

Returns from Tvardi Therapeutics Inc. Stock

-₹89,723 (-89.72%)

Dollar Impact

₹918 (+0.92%)

Indian Investors' Interest in Tvardi Therapeutics Inc. Stock

Search interest for Tvardi Therapeutics Inc. Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 23, 2026 to June 22, 2026

Change:33% versus previous 30 day period

Tvardi Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	3	2	0	2	1	2	-	-	-	-
Gross Profit	2	1	0	2	1	2	0	-	-	-
Operating Income	-32	-29	-7	-5	-10	-2	-8	-5	-7	-7
EBITDA	-31	-28	-6	-3	-10	-2	4	-5	-7	-6
Interest Expense	-	1	1	1	2	2	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-32	-30	-6	-5	-12	-4	4	-5	-7	-6
Income Tax Expense	-	-	-	-	0	-	-	-	-	-
Net Income	-32	-30	-6	-5	-12	-4	4	-5	-7	-6
Net Profit Margin	-1076.46%	-1437.75%	-703.83%	-215.69%	-873.33%	-190.97%	0.00%	0.00%	0.00%	0.00%

Tvardi Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	135	23	41	20	7	-
Gross Profit	-	21	34	14	6	0
Operating Income	5	-89	-87	-121	-55	-26
EBITDA	8	-86	-83	-117	-62	-18
Interest Expense	-	-	0	-	8	-
Depreciation	-	-	0	0	0	0
Income Before Tax	7	-88	-85	-118	-71	-18
Income Tax Expense	0	-	-	-	0	-
Net Income	8	-88	-85	-118	-70	-18
Net Profit Margin	6.23%	-384.06%	-204.16%	-565.21%	-992.95%	0.00%

Tvardi Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-30	-20	-12	-7	-4	0	-5	-7	-6
Operating Cash Flow	-30	-12	-13	-4	-4	-8	-4	-5	-5
Investing Cash Flow	25	15	2	5	-10	-20	5	5	-
Financing Cash Flow	0	0	0	-1	1	22	0	0	-
Change in Cash	-5	2	-10	0	-3	-13	0	0	0

Tvardi Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-88	-20	-17	-70	-18
Operating Cash Flow	-60	-17	-21	-60	-23
Investing Cash Flow	-4	-22	22	48	-10
Financing Cash Flow	46	0	0	-3	22
Change in Cash	-18	-39	1	-14	-10

Global Institutional Holdings in Tvardi Therapeutics Inc.

Funds	Holdings
Silvercrest Asset Management Group LLC	1.08%
Squarepoint Ops LLC	0.35%
Bank of New York Mellon Corp	0.19%
XTX Topco Ltd	0.14%
American Financial Group Inc	2.38%

See all

Insights on Tvardi Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 109.5%
NEGATIVE IMPACT
Price Dip
In the last 1 month, TVRD stock has moved down by -26.7%

About Tvardi Therapeutics Inc.

Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.

Organisation	Tvardi Therapeutics Inc.
Headquarters	3 Sugar Creek Center Boulevard, Sugar Land, TX, United States, 77478
Industry	Biotechnology
CEO	Dr. Imran Alibhai Ph.D.
E-voting on shares	Click here to vote

Key Management of Tvardi Therapeutics Inc.

Name	Title
Dr. Imran Alibhai Ph.D.	CEO & Director
Mr. Dan Conn J.D., M.B.A.	CFO & Corporate Secretary
Dr. John Kauh M.D.	Chief Medical Officer
Dr. Ronald A. DePinho M.D.	Co-Founder & Chairman of Scientific Advisory Board
Dr. Michael T. Lewis Ph.D.	Co-Founder & Scientific Advisory Board Member
Dr. Yixin Chen Ph.D.	Vice President of CMC
Mr. David J. Tweardy M.D.	Co-Founder & Scientific Advisory Board Member
Dr. Jeffrey Larson DABT, Ph.D.	Senior Vice President of R&D
Mr. Stephen O'Brien CPA	VP of Finance & Corporate Controller

FAQs

What is Tvardi Therapeutics Inc. share price today?

Tvardi Therapeutics Inc. share price today is $2.63 as on June 19, 2026 at 8:46 am IST at the close of the market. Tvardi Therapeutics Inc. share today touched a day high of $2.65 and a low of $2.48.

What is the 52 week high and 52 week low for Tvardi Therapeutics Inc. share?

Tvardi Therapeutics Inc. share touched a 52 week high of $43.65 on October 10, 2025 and a 52 week low of $2.48 on June 18, 2026. Tvardi Therapeutics Inc. stock price today i.e. June 19, 2026 at 8:46 am IST is closed at $2.63,which is 93.97% down from its 52 week high and 6.26% up from its 52 week low.

What is Tvardi Therapeutics Inc.'s market capitalisation today?

Tvardi Therapeutics Inc. market capitalisation is $0.00T as on June 19, 2026 at 8:46 am IST.

How to invest in Tvardi Therapeutics Inc. Stock (TVRD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tvardi Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tvardi Therapeutics Inc. Shares that will get you 0.5703 shares as per Tvardi Therapeutics Inc. share price of $2.63 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Tvardi Therapeutics Inc. Stock (TVRD) from India?

Indian investors can start investing in Tvardi Therapeutics Inc. (TVRD) shares with as little as ₹94.31 or $1 (as of June 22, 2026 at 5:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Tvardi Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 22, 2026 at 5:42 am IST). Based on Tvardi Therapeutics Inc. share’s latest price of $2.63 as on June 19, 2026 at 8:46 am IST, you will get 3.8023 shares of Tvardi Therapeutics Inc.. Learn more about fractional shares .